AmSurg CEO Christopher Holden Sells 5k Shares

On Sept. 9, Christopher Holden, CEO of ambulatory surgery center management and development company AmSurg, sold 5,000 shares of the company’s stock, according to a WKRB News & Analysis report.

Advertisement

The transaction, legally disclosed through the Securities & Exchange Commission, was a total of $187,800. The shares were sold for an average price of $37.56 each.

More Articles on Transactions and Valuation Issues:
Ambulatory Surgery Centers, Urgent Care Centers & Others: Where Do Ancillary Services Stand in the Race for Consolidation?
How Does Payer Mix Vary by Surgery Center Revenue? 18 Statistics
UCLA Health Sells Outpatient Surgery Center, Medical Building for $54M

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.